{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:44:08Z","timestamp":1794480248582,"version":"4.9.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jbspin.2025.105904","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:20:31Z","timestamp":1744658431000},"page":"105904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Weighing in on obesity and psoriatic arthritis\u00a0\u2013\u00a0Time to move beyond association to robust randomised trials"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-7311","authenticated-orcid":false,"given":"Stefan","family":"Siebert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn D.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2025.105904_bib0360","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0365","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00296-021-04971-8","article-title":"Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi-center study","volume":"42","author":"Gok","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2025.105904_bib0370","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","article-title":"Comorbidities in psoriatic arthritis: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2025.105904_bib0375","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/acr.25230","article-title":"Comorbidities in early psoriatic arthritis: data from the Metabolic Disturbances in Psoriatic Arthritis Cohort Study","volume":"76","author":"Ishchenko","year":"2024","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2025.105904_bib0380","first-page":"1815","article-title":"Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations","volume":"41","author":"Scriffignano","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0385","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/jcm10143194","article-title":"Comparison of psoriatic arthritis and rheumatoid arthritis patients across body mass index categories in Switzerland","volume":"10","author":"Vallejo-Yag\u00fce","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0390","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41584-019-0256-0","article-title":"Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions","volume":"15","author":"Ferguson","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0395","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/1756-185X.14147","article-title":"Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis","volume":"24","author":"Loganathan","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0400","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40744-022-00502-4","article-title":"Discrepancy in metabolic syndrome between psoriatic arthritis and rheumatoid arthritis: a direct comparison of two cohorts in one center","volume":"10","author":"Li","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2025.105904_bib0405","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/rheumatology\/kez192","article-title":"Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank","volume":"58","author":"Ferguson","year":"2019","journal-title":"Rheumatol U K"},{"key":"10.1016\/j.jbspin.2025.105904_bib0410","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/rheumatology\/keaa604","article-title":"Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity\u00a0\u2013\u00a0a cross-sectional study","volume":"60","author":"Ferguson","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105904_bib0415","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-023-03085-9","article-title":"More than skin-deep: visceral fat is strongly associated with disease activity, function and metabolic indices in psoriatic disease","volume":"25","author":"Blake","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105904_bib0420","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinte.167.15.1670","article-title":"Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses\u2019 Health Study II","volume":"167","author":"Setty","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0425","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","article-title":"Obesity and risk of incident psoriatic arthritis in US women","volume":"71","author":"Li","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0430","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: a population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0435","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjd.18227","article-title":"Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis","volume":"182","author":"Green","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0440","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/acr.24121","article-title":"Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a population-based study in Norway","volume":"73","author":"Thomsen","year":"2021","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2025.105904_bib0445","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jamasurg.2016.4610","article-title":"Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery","volume":"152","author":"Egeberg","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jbspin.2025.105904_bib0450","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/oby.21955","article-title":"Bariatric surgery and the incidence of psoriasis and psoriatic arthritis in the Swedish Obese Subjects Study","volume":"25","author":"Maglio","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jbspin.2025.105904_bib0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002739","article-title":"Evidence of a causal relationship between body mass index and psoriasis: a Mendelian randomization study","volume":"16","author":"Budu-Aggrey","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0460","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/rheumatology\/keac403","article-title":"Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization","volume":"62","author":"Zhao","year":"2023","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105904_bib0465","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3899\/jrheum.160532","article-title":"The association between obesity and clinical features of psoriatic arthritis: a case-control study","volume":"44","author":"Eder","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0470","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjd.12001","article-title":"Interactions between adiposity and genetic polymorphisms on the risk of psoriasis","volume":"168","author":"Li","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0475","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/rheumatology\/keae399","article-title":"Subclinical psoriatic arthritis and disease interception-where are we in 2024?","volume":"64","author":"L\u00f3pez-Medina","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105904_bib0480","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/rheumatology\/kew326","article-title":"The influence of obesity on response to tumour necrosis factor-\u03b1 inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries","volume":"55","author":"H\u00f8jgaard","year":"2016","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105904_bib0485","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/annrheumdis-2013-204448","article-title":"Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis","volume":"74","author":"Eder","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0490","doi-asserted-by":"crossref","first-page":"e003157","DOI":"10.1136\/rmdopen-2023-003157","article-title":"Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study","volume":"9","author":"Leung","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2025.105904_bib0495","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40744-020-00202-x","article-title":"The impact of comorbidity on patient-reported outcomes in psoriatic arthritis: a systematic literature review","volume":"7","author":"Ca\u00f1ete","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2025.105904_bib0500","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/acr.21711","article-title":"Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis","volume":"65","author":"di Minno","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2025.105904_bib0505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3899\/jrheum.171034","article-title":"Predictors of achieving remission among patients with psoriatic arthritis initiating a tumor necrosis factor inhibitor","volume":"46","author":"Ogdie","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0510","doi-asserted-by":"crossref","first-page":"e061474","DOI":"10.1136\/bmjopen-2022-061474","article-title":"Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort","volume":"12","author":"Vallejo-Yag\u00fce","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jbspin.2025.105904_bib0515","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3899\/jrheum.211037","article-title":"Potential impact of sex and BMI on response to therapy in psoriatic arthritis: post hoc analysis of results from the SEAM-PsA Trial","volume":"49","author":"Mease","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0520","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41584-024-01083-y","article-title":"Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow","volume":"20","author":"Siebert","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0525","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s40744-022-00461-w","article-title":"Clinical characteristics of potential \u201cdifficult-to-treat\u201d patients with psoriatic arthritis: a retrospective analysis of a longitudinal cohort","volume":"9","author":"Perrotta","year":"2022","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.jbspin.2025.105904_bib0530","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/rheumatology\/keae263","article-title":"Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry","volume":"63","author":"Vassilakis","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105904_bib0535","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13075-025-03518-7","article-title":"Burden and determinants of multi-b\/tsDMARD failure in psoriatic arthritis","volume":"27","author":"Haberman","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105904_bib0540","doi-asserted-by":"crossref","first-page":"105177","DOI":"10.1016\/j.jbspin.2021.105177","article-title":"Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: a multi-center study","volume":"88","author":"Duru\u00f6z","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2025.105904_bib0545","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/rheumatology\/keab338","article-title":"Being overweight is associated with not reaching low disease activity in women but not men with psoriatic arthritis","volume":"61","author":"Mulder","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105904_bib0550","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-020-05169-6","article-title":"Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes","volume":"63","author":"Wright","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jbspin.2025.105904_bib0555","doi-asserted-by":"crossref","first-page":"e70080","DOI":"10.1002\/iid3.70080","article-title":"Obesity and chronic inflammation: implications for rheumatoid arthritis, spondyloarthritis, and ulcerative colitis","volume":"13","author":"Corrado","year":"2025","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0560","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/CS20200895","article-title":"The complex role of adipokines in obesity, inflammation, and autoimmunity","volume":"135","author":"Taylor","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jbspin.2025.105904_bib0565","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/jcm6070068","article-title":"Pathogenic role of IL-17-producing immune cells in obesity, and related inflammatory diseases","volume":"6","author":"Chehimi","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0570","doi-asserted-by":"crossref","first-page":"17469","DOI":"10.3390\/ijms160817469","article-title":"Interleukin-17A gene expression in morbidly obese women","volume":"16","author":"Zapata-Gonzalez","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jbspin.2025.105904_bib0575","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11154-016-9381-0","article-title":"Adipokines in psoriasis: an important link between skin inflammation and metabolic alterations","volume":"17","author":"Wolk","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jbspin.2025.105904_bib0580","doi-asserted-by":"crossref","first-page":"e003821","DOI":"10.1136\/rmdopen-2023-003821","article-title":"Sex differences in cytokines and adipokines in obese patients with PsA and controls undergoing a weight loss intervention","volume":"10","author":"Landgren","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2025.105904_bib0585","doi-asserted-by":"crossref","first-page":"368","DOI":"10.15386\/mpr-2631","article-title":"Prevalence of metabolic syndrome and chronic inflammation in psoriasis before and after biologic therapy: a prospective study","volume":"96","author":"Timis","year":"2023","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.jbspin.2025.105904_bib0590","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320944777","article-title":"Changes in metabolic parameters in psoriatic patients treated with secukinumab","volume":"11","author":"Wang","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0595","doi-asserted-by":"crossref","first-page":"101047","DOI":"10.1016\/j.molmet.2020.101047","article-title":"Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome","volume":"41","author":"Evans","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.jbspin.2025.105904_bib0600","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0605","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/oby.2011.397","article-title":"Obesity and pain are associated in the United States","volume":"20","author":"Stone","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jbspin.2025.105904_bib0610","doi-asserted-by":"crossref","first-page":"152060","DOI":"10.1016\/j.semarthrit.2022.152060","article-title":"The economic burden of fibromyalgia: a systematic literature review","volume":"56","author":"D\u2019Onghia","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2025.105904_bib0615","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2012-202812","article-title":"Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor \u03b1 blockers","volume":"73","author":"Di Minno","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0620","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-019-1810-5","article-title":"Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105904_bib0625","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s10067-022-06164-5","article-title":"The impact of a structured weight-loss treatment on physical fitness in patients with psoriatic arthritis and obesity compared to matched controls: a prospective interventional study","volume":"41","author":"Bilberg","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0630","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13075-020-02350-5","article-title":"Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up","volume":"22","author":"Klingberg","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105904_bib0635","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/bjd.17741","article-title":"Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically appraised topic","volume":"181","author":"Mahil","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0640","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41591-024-03384-x","article-title":"Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial","volume":"31","author":"Combet","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.02.013","article-title":"Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act","author":"Sattar","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105904_bib0650","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2213-8587(23)00385-6","article-title":"5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study","volume":"12","author":"Lean","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0655","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0660","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0665","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0670","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jbspin.2025.105904_bib0675","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2012.04609.x","article-title":"Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study","volume":"27","author":"Ahern","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0680","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bjd.12886","article-title":"Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal \u03b3\u03b4 T-cell number: a prospective case-series study","volume":"171","author":"Buysschaert","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2025.105904_bib0685","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.diabres.2019.03.002","article-title":"Treatment with liraglutide, a glucagon-like peptide-1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: a prospective cohort study","volume":"150","author":"Xu","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jbspin.2025.105904_bib0690","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/09546634.2020.1826392","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial","volume":"33","author":"Lin","year":"2022","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jbspin.2025.105904_bib0695","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/09546634.2019.1708853","article-title":"Liraglutide improved inflammation via mediating IL-23\/Th-17 pathway in obese diabetic mice with psoriasiform skin","volume":"32","author":"Chen","year":"2021","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jbspin.2025.105904_bib0700","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.medcli.2023.05.021","article-title":"Effects of liraglutide among patients living with psoriasis and obesity","volume":"161","author":"Nicolau","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jbspin.2025.105904_bib0705","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/biom15010046","article-title":"Effects of semaglutide treatment on psoriatic lesions in obese patients with type 2 diabetes mellitus: an open-label, randomized clinical trial","volume":"15","author":"Petkovi\u0107-Dabi\u0107","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbspin.2025.105904_bib0710","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:27:29Z","timestamp":1758828449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X25000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1297319X25000636"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105904","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weighing in on obesity and psoriatic arthritis\u00a0\u2013\u00a0Time to move beyond association to robust randomised trials","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\ufffdt\ufffd Fran\ufffdaise de Rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105904"}}